Findings presented during the developmental therapeutics session at the ASCO 2020 Virtual Scientific Program CULVER [...]
--Observed clinical activity, including durable and complete tumour responses, suggests that MTL‑CEBPA may increase the [...]
Results demonstrate inverse relationship between presence of ecDNA and biomarkers that predict response to pembrolizumab [...]
MENLO PARK, Calif.--(BUSINESS WIRE)--#ASCO--Personalis, Inc., (Nasdaq: PSNL) a leader in advanced genomics for cancer, today [...]
Research includes a potential new drug for colorectal cancer, as well as new studies on [...]
Advances demonstrated in combining omic and clinical data, using real-world data and pooled clinical trial [...]
Presentations and e-publications from SCCA clinicians to feature the latest research on breast, gastrointestinal, genitourinary, [...]
Scientific data describe clinical experience and potential of Rubraca in multiple solid tumor types BOULDER, [...]
– Scientific Advancements Seek to Address Therapeutic Needs in Underserved Oncology Communities, Including Rare Leukemias [...]
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new [...]